Copper oxide nanoparticles induce anticancer activity in A549 lung cancer cells by inhibition of histone deacetylaseVisa övriga samt affilieringar
2018 (Engelska)Ingår i: Biotechnology letters, ISSN 0141-5492, E-ISSN 1573-6776, Vol. 40, nr 2, s. 249-256Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Copper oxide nanoparticles (CuO NPs) promoting anticancer activity may be due to the regulation of various classes of histone deacetylases (HDACs). Green-synthesized CuO NPs significantly arrested total HDAC level and also suppressed class I, II and IV HDACs mRNA expression in A549 cells. A549 cells treated with CuO NPs downregulated oncogenes and upregulated tumor suppressor protein expression. CuO NPs positively regulated both mitochondrial and death receptor-mediated apoptosis caspase cascade pathway in A549 cells. Green-synthesized CuO NPs inhibited HDAC and therefore shown apoptosis mediated anticancer activity in A549 lung cancer cell line.
Ort, förlag, år, upplaga, sidor
Springer Netherlands, 2018. Vol. 40, nr 2, s. 249-256
Nyckelord [en]
Anticancer activity; Apoptosis; A549 cells; Copper oxide nanoparticles; Epigenetic; Histone deacetylase
Nationell ämneskategori
Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Identifikatorer
URN: urn:nbn:se:liu:diva-145455DOI: 10.1007/s10529-017-2463-6ISI: 000425115100003PubMedID: 29116558Scopus ID: 2-s2.0-85033389854OAI: oai:DiVA.org:liu-145455DiVA, id: diva2:1192868
Anmärkning
Funding Agencies|Department of Educational Technology, Bharathidasan University, Tiruchirappalli
2018-03-232018-03-232018-04-03Bibliografiskt granskad